Buy & Sell TG Therapeutics Inc (TGTX) – TG Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $6.56BMarket Cap
- HealthSector
- -12.82%3M Drawdown
- $6.80BEnterprise Value
- -Dividend Yield
- 3 daysTypical Hold Time
TG Therapeutics Inc (TGTX) is currently valued at a market capitalization of $6.56B, with an enterprise value of $6.80B. Over the past 52 weeks, TG Therapeutics Inc has traded between a low of $26.39 and a high of $43.26, highlighting its annual price range. Over the past three months, TG Therapeutics Inc has recorded a drawdown of -12.82%, reflecting recent price volatility. On average, investors hold TG Therapeutics Inc for approximately 3 days, indicating typical investor behavior on the platform.
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Most Recent News
China probes EV makers after owners report up to 125 miles lost range post-software updates.
Chinese authorities have launched an investigation into electric vehicle (EV) manufacturers after owners reported a loss of up to 125 miles (200 km) in driving range following software updates. The probe, triggered by complaints of battery degradatio...
Foreign investors hold a record $21.3T in US stocks, with equity allocation hitting 63%, surpassing the dot-com bubble peak.
Foreign investors have dramatically increased their holdings in US equities, now owning a record $21.3 trillion and allocating 63% of their portfolios to US stocks. This allocation surpasses the peak seen during the 2000 dot-com bubble by about 10 pe...
ABB invests $200M in Europe to boost medium-voltage tech for power grid modernization.
ABB is investing $200 million over three years to expand its medium-voltage manufacturing capacity across Europe, including a $100 million facility in Italy and projects in Bulgaria, Finland, Germany, Norway, and Poland. This investment aims to suppo...